Clinical trial
Nutritional Status of Patients With Gastroenteropancreatic Neuroendocrine Tumors in Spain: NUTRIGETNE
NCT04986085 is registered in ClinicalTrials.gov with Grupo Espanol de Tumores Neuroendocrinos as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nutritional Status of Patients With Gastroenteropancreatic Neuroendocrine Tumors in Spain: NUTRIGETNE
- Lead sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 24, 2021
- Completion date
- February 23, 2024
- Enrollment
- 399 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
gastroenteropancreatic neuroendocrine tumor